Yiviva_Logo_(R)_1024px_300dpi.png
Yiviva Wins 2 Top Awards at SAPA Investment Forum and Road Show for Innovative Systems Biology Approach to Treat Cancer
30 juil. 2021 08h00 HE | Yiviva
NEW YORK and SHANGHAI, China, July 30, 2021 (GLOBE NEWSWIRE) -- Yiviva, a clinical-stage biotechnology company that uses a systems-biology approach to treat aging-associated diseases, won two top...
22157.jpg
Global $3.32 Bn Interventional Oncology Devices Market to 2030: Embolization Devices, Ablation Devices, & Support Devices
16 juil. 2021 05h53 HE | Research and Markets
Dublin, July 16, 2021 (GLOBE NEWSWIRE) -- The "Interventional Oncology Devices Global Market Report 2021: COVID-19 Growth and Change to 2030" report has been added to ResearchAndMarkets.com's...
Reports and Data.jpeg-01
Computer Aided Detection (CAD) Market to Reach USD 1579.5 Million In 2028 | Reports and Data
09 juin 2021 09h00 HE | Reports and Data
New York, June 09, 2021 (GLOBE NEWSWIRE) -- Rising prevalence of chronic diseases and growing demand for computational assistance are key factors surging global market growth  Market size: USD...
New Logo.png
Provectus Biopharmaceuticals Announces Presentation of Full Study Data from Metastatic Neuroendocrine Cancer Phase 1 Trial of PV-10® at American Society of Clinical Oncology (ASCO) 2021 Annual Meeting
04 juin 2021 09h00 HE | Provectus Biopharmaceuticals Inc.
     — Systemic disease control achieved in heavily pre-treated liver cancer patients      — 83% DCR; median PFS of 9.2 months; median OS of 22.5 months; half of patients undergoing response...
22157.jpg
The Worldwide Interventional Oncology Industry is Projected to Reach $2.9 Billion by 2026 at a CAGR of 6.8% from 2020
01 juin 2021 07h43 HE | Research and Markets
Dublin, June 01, 2021 (GLOBE NEWSWIRE) -- The "Interventional Oncology Market by Product (Radiofrequency, microwave, embolization, guidewires), Procedure (Thermal, Non-Thermal Ablation, TACE, TARE,...
Logo (3).png
Electric Vehicle (EV) Market Worth $2,495.4 Billion by 2027, Growing at a CAGR of 33.6% From 2020- Exclusive Report by Meticulous Research®
11 mai 2021 07h10 HE | Meticulous Market Research Pvt. Ltd.
London, May 11, 2021 (GLOBE NEWSWIRE) -- According to a new market research report “Electric Vehicle (EV) Market by Vehicle Type (Passenger Vehicles, LCVs, HCVs, Two-wheelers, e-Scooters &...
Logo.png
Advanced Liver Cancer Drug Pipeline Prospers with an Inrush of Pharma Companies and Emerging Novel Therapies
29 avr. 2021 20h30 HE | DelveInsight Business Research LLP
Los Angeles, USA, April 29, 2021 (GLOBE NEWSWIRE) -- Advanced Liver Cancer Drug Pipeline Prospers with an Inrush of Pharma Companies and Emerging Novel Therapies  A comprehensive analysis of...
Logo (3).png
Haematococcus Pluvialis Market Worth $148.1 million by 2027- Exclusive Report Covering Pre and Post COVID-19 Market Analysis by Meticulous Research® & EABA
10 nov. 2020 08h00 HE | Meticulous Market Research Pvt. Ltd.
London, Nov. 10, 2020 (GLOBE NEWSWIRE) -- According to a new market research report titled “Haematococcus Pluvialis Market by Product (Astaxanthin Ingredients (Oleoresin, Beadlets), Astaxanthin Bulk...
22157.jpg
Global $136.7 Billion Oncology Market to 2025
30 oct. 2020 03h13 HE | Research and Markets
Dublin, Oct. 30, 2020 (GLOBE NEWSWIRE) -- The "Oncology Market - Forecast (2020 - 2025)" report has been added to ResearchAndMarkets.com's offering. Oncology Market size was valued at $136.7...
Adaptimmune logo Colour_white background_no strap.jpg
Promising Data from Phase 1 Trial with ADP-A2AFP in Liver Cancer at the International Liver Congress Confirm Safety Profile and Demonstrate Potential Benefit for Patients
28 août 2020 10h30 HE | Adaptimmune Therapeutics plc
PHILADELPHIA and OXFORDSHIRE, United Kingdom, Aug. 28, 2020 (GLOBE NEWSWIRE) -- Adaptimmune Therapeutics plc (“Adaptimmune”)(Nasdaq: ADAP), a leader in cell therapy to treat cancer, presented data...